ERIN MARQUEZ: Open Payments
NPI 1992412290 · KINGSBURG, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 86 payments from 28 companies in 2025. Trend: 2023 $356 · 2024 $1,536 · 2025 $1,738
Food & beverage: $1,738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $261 |
| PFIZER INC. | 5 | $221 |
| Novo Nordisk Inc | 13 | $170 |
| Lilly USA, LLC | 13 | $137 |
| ABIOMED | 3 | $97 |
| Axsome Therapeutics, Inc. | 4 | $89 |
| Xeris Pharmaceuticals, Inc. | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Antares Pharma, Inc. | 2 | $58 |
| Verity Pharmaceuticals Inc. | 3 | $56 |
Products named: ZAVZPRET, QULIPTA, MOUNJARO, NURTEC ODT, REXULTI, RECORLEV, Wegovy, VRAYLAR.
Industry payments across CA — which companies pay providers there.
